Anondita Medicare Limited
Bookbuilding IPO · NSE
- Price band
- ₹137 - ₹145
- Lot size
- 1,000 shares
- Issue amount
- ₹69.5 cr
- Total subscription
- 301.09×
- Opens
- 22 Aug 2025
- Closes
- 26 Aug 2025
- Allotment
- 28 Aug 2025
- Listing
- 1 Sept 2025
Offer at a glance
Issue overview
- Issue size
- 47,93,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,37,000
- Fresh issue
- ₹69.5 cr
- Offer for sale
- ₹0 cr
- Registrar
- Maashitla Securities Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,45,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,32,93,618
- Shares after issue
- 1,80,86,618
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 2,000 | ₹2,90,000 |
| sHNI | 3 | 3,000 | ₹4,35,000 |
| bHNI | 7 | 7,000 | ₹10,15,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 169 |
| NIB | 0 | 60,918 |
| RETAIL | 793 | 2,27,121 |
| HNIs(10L +) | 151 | 38,388 |
| HNIs (2-10L) | 76 | 22,530 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 13.14 | 2,010.4 |
| RETAIL | 23 | 6,586.51 |
| HNIs 2+ | 3.29 | 1,031.96 |
| HNIs 10+ | 6.58 | 4,223.75 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 14.04 | 0 | 0 |
| ROE | 41.71 | 36.31 | 3.99 |
| ROCE | 0 | 0 | 0 |
| RONW | 41.71 | 36.31 | 3.99 |
| PRE IPO(PE) | 11.74 | 0 | 0 |
| POST IPO(PE) | 15.98 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Anondita Medicare Limited, founded in March 2024, is a condom manufacturer best known for its flagship brand “COBRA,” producing around 562 million flavored male condoms annually. Its manufacturing facility is located in Noida, Uttar Pradesh, and the company exports to Southeast Asia, Africa, and the Middle East. Partnering with global health organizations, NGOs, and governments, Anondita supports family planning and public health initiatives. With a strong distribution network, it ensures timely delivery through wholesalers, retailers, e-commerce platforms, and government health programs. As of July 31, 2025, the company employed 280 people.
Strengths
- Regional Market Leadership: strong brand presence and recognition in North India
- Innovative Product Portfolio: wide range including flavored and specialty condoms
- Strong Distribution Network: established supply chain across domestic and international markets
Risk factors
- Cash Flow Strain: past and possible future negative cash flows may impact growth and operations
- Revenue Concentration Risk: heavy dependence on top 10 customers increases vulnerability
- Government Contract Reliance: significant dependence on tenders exposes business to regulatory and compliance risks
Promoters
Mr. Anupam Ghosh
Mrs. Sonia Ghosh
Mr. Reshant Ghosh
Registrar & documents
Lead manager
Narnolia Financial Services Limited
Registrar & contacts
Maashitla Securities Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Flat No.704 Narmada Block, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, New Delhi, 110070
0120-4520300
[email protected]Company website ↗Understanding ANONDITA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.